Clostridiodes difficile Treatment Guided by Polymerase Chain Reaction Stool Testing Does not Alter Outcomes for Patients With Inflammatory Bowel Disease

被引:0
|
作者
Chandrabos, Ceena [1 ]
Chin, Kana [2 ]
Liu, Yan [3 ]
Kohn, Nina [4 ]
Swaminath, Arun [5 ]
Sultan, Keith [6 ]
机构
[1] Northwell Hlth North Shore Univ Hosp, Dept Med, 300 Community Dr, Manhasset, NY 11030 USA
[2] Northwell Hlth Forest Hills Hosp, Dept Med, 102-01 66th Rd, Forest Hills, NY 11375 USA
[3] Feinstein Inst Med Res, Bioinformat, 350 Community Dr, Manhasset, NY 11030 USA
[4] Feinstein Inst Med Res, Biostat, 350 Community Dr, Manhasset, NY 11030 USA
[5] Northwell Hlth Lenox Hill Hosp, Div Gastroenterol, 100 East 77th St, New York, NY 10075 USA
[6] Northwell Hlth North Shore Univ Hosp, Div Gastroenterol, Manhasset, NY 11021 USA
来源
关键词
D O I
10.14740/jocmr4610
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:572 / 574
页数:3
相关论文
共 50 条
  • [31] Polymerase Chain Reaction Test for Clostridium difficile Toxin B Gene Reveals Similar Prevalence Rates in Children With and Without Inflammatory Bowel Disease
    Lamouse-Smith, Esi S. N.
    Weber, Sarah
    Rossi, Richard F.
    Neinstedt, Liliane J.
    Mosammaparast, Nima
    Sandora, Thomas J.
    McAdam, Alexander J.
    Bousvaros, Athos
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2013, 57 (03): : 293 - 297
  • [32] Temporal Trends in Disease Outcomes Related to Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease
    Ananthakrishnan, Ashwin N.
    McGinley, Emily L.
    Saeian, Kia
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (04) : 976 - 983
  • [33] Testing for Clostridium difficile in Patients Newly Diagnosed with Inflammatory Bowel Disease in a Community Setting
    Krishnarao, Anita
    de Leon, Lauren
    Bright, Renee
    Moniz, Heather
    Law, Meaghan
    Leleiko, Neal
    Sands, Bruce E.
    Merrick, Marjorie
    Shapiro, Jason
    Wallenstein, Sylvan
    Giacalone, Julie
    Shah, Samir A.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (03) : 564 - 569
  • [34] Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease
    Horton, Henry A.
    Dezfoli, Seper
    Berel, Dror
    Hirsch, Julianna
    Ippoliti, Andrew
    McGovern, Dermot
    Kaur, Manreet
    Shih, David
    Dubinsky, Marla
    Targan, Stephan R.
    Fleshner, Phillip
    Vasiliauskas, Eric A.
    Grein, Jonathan
    Murthy, Rekha
    Melmed, Gil Y.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5054 - 5059
  • [35] TREATMENT FOR REDUCING RECURRENCE OF C. DIFFICILE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Dargan, Andrew R.
    Durney, Philip
    Cao, Christopher
    Sham, Catherine
    Choudhary, Cuckoo
    GASTROENTEROLOGY, 2019, 156 (06) : S893 - S894
  • [36] Rifaximin and treatment of recurrent Clostridium difficile infection in patients with inflammatory bowel disease
    Issa, Mazen
    Weber, Lydia R.
    Brandenburg, Heather
    Emmons, Jeanne
    Skaros, Sue
    Knox, Josh F.
    Beaulieu, Dawn B.
    Binion, David G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S469 - S469
  • [37] Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease
    Alireza Meighani
    Benjamin R. Hart
    Kassem Bourgi
    Nichole Miller
    Ajin John
    Mayur Ramesh
    Digestive Diseases and Sciences, 2017, 62 : 2870 - 2875
  • [38] Novel Risk Factors and Outcomes in Inflammatory Bowel Disease Patients With Clostridium difficile Infection
    Voth, Elida
    Solanky, Dipesh
    Loftus, Edward V., Jr.
    Pardi, Darrell
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S442 - S442
  • [39] Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
    Voth, Elida
    Solanky, Dipesh
    Loftus, Edward V., Jr.
    Pardi, Darrell S.
    Khanna, Sahil
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [40] Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease
    Ananthakrishnan, A. N.
    Guzman-Perez, R.
    Gainer, V.
    Cai, T.
    Churchill, S.
    Kohane, I.
    Plenge, R. M.
    Murphy, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (07) : 789 - 795